Genetic and functional diversity of propagating cells in glioblastoma

Stem Cell Reports

Volumn 4, Issue 1, 2015, Pages 7-15

  Piccirillo, Sara G M ^a   Colman, Sue ^b   Potter, Nicola E ^b   Van Delft, Frederik W ^b,e   Lillis, Suzanne ^c   Carnicer, Maria Jose ^b   Kearney, Lyndal ^b   Watts, Colin ^a,d   Greaves, Mel ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; COPY NUMBER VARIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE CELL ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STEM CELL TRANSPLANTATION; ANIMAL; BRAIN TUMOR; DISEASE COURSE; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PATHOLOGY; PHENOTYPE; TUMOR CELL LINE; XENOGRAFT;

MUS;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GLIOBLASTOMA; HETEROGRAFTS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; NEOPLASTIC STEM CELLS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SINGLE-CELL ANALYSIS;

EID: 84920876120     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2014.11.003     Document Type: Article

References (37)

1. K. Anderson, C. Lutz, F.W. van Delft, C.M. Bateman, Y. Guo, S.M. Colman, H. Kempski, A.V. Moorman, I. Titley, and J. Swansbury Genetic variegation of clonal architecture and propagating cells in leukaemia Nature 469 2011 356 361
2. U. Andersson, J. Schwartzbaum, F. Wiklund, S. Sjöström, Y. Liu, S. Tsavachidis, A. Ahlbom, A. Auvinen, H. Collatz-Laier, and M. Feychting A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk Acta Oncol. 49 2010 767 775
3. S. Bao, Q. Wu, S. Sathornsumetee, Y. Hao, Z. Li, A.B. Hjelmeland, Q. Shi, R.E. McLendon, D.D. Bigner, and J.N. Rich Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res. 66 2006 7843 7848
4. R. Bonavia, M.M. Inda, W.K. Cavenee, and F.B. Furnari Heterogeneity maintenance in glioblastoma: a social network Cancer Res. 71 2011 4055 4060
5. R. Chen, M.C. Nishimura, S.M. Bumbaca, S. Kharbanda, W.F. Forrest, I.M. Kasman, J.M. Greve, R.H. Soriano, L.L. Gilmour, and C.S. Rivers A hierarchy of self-renewing tumor-initiating cell types in glioblastoma Cancer Cell 17 2010 362 375
6. J. Chen, Y. Li, T.S. Yu, R.M. McKay, D.K. Burns, S.G. Kernie, and L.F. Parada A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 2012 522 526
7. J.E. Dick, M. Bhatia, O. Gan, U. Kapp, and J.C. Wang Assay of human stem cells by repopulation of NOD/SCID mice Stem Cells 15 Suppl 1 1997 199 203 discussion 204-207
8. K.M. Egan, L.B. Nabors, J.J. Olson, A.N. Monteiro, J.E. Browning, M.H. Madden, and R.C. Thompson Rare TP53 genetic variant associated with glioma risk and outcome J. Med. Genet. 49 2012 420 421
9. T.M. Fael Al-Mayhani, S.L. Ball, J.W. Zhao, J. Fawcett, K. Ichimura, P.V. Collins, and C. Watts An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours J. Neurosci. Methods 176 2009 192 199
10. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco, and A. Vescovi Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res. 64 2004 7011 7021
11. M.L. Goodenberger, and R.B. Jenkins Genetics of adult glioma Cancer Genet. 205 2012 613 621
12. M. Greaves Cancer stem cells as 'units of selection' Evol. Appl. 6 2013 102 108
13. M. Greaves, and C.C. Maley Clonal evolution in cancer Nature 481 2012 306 313
14. S.W. Horsley, S. Colman, M. McKinley, C.M. Bateman, M. Jenney, T. Chaplin, B.D. Young, M. Greaves, and L. Kearney Genetic lesions in a preleukemic aplasia phase in a child with acute lymphoblastic leukemia Genes Chromosomes Cancer 47 2008 333 340
15. B.E. Johnson, T. Mazor, C. Hong, M. Barnes, K. Aihara, C.Y. McLean, S.D. Fouse, S. Yamamoto, H. Ueda, and K. Tatsuno Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma Science 343 2014 189 193
16. V. Jung, B.F. Romeike, W. Henn, W. Feiden, J.R. Moringlane, K.D. Zang, and S. Urbschat Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells J. Neuropathol. Exp. Neurol. 58 1999 993 999
17. A. Kreso, and J.E. Dick Evolution of the cancer stem cell model Cell Stem Cell 14 2014 275 291
18. S.E. Little, S. Popov, A. Jury, D.A. Bax, L. Doey, S. Al-Sarraj, J.M. Jurgensmeier, and C. Jones Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity Cancer Res. 72 2012 1614 1620
19. A. Marusyk, V. Almendro, and K. Polyak Intra-tumour heterogeneity: a looking glass for cancer? Nat. Rev. Cancer 12 2012 323 334
20. M.K. Nicholas Glioblastoma multiforme: evidence-based approach to therapy Expert Rev. Anticancer Ther. 7 12, Suppl 2007 S23 S27
21. G.C. Nickel, J. Barnholtz-Sloan, M.P. Gould, S. McMahon, A. Cohen, M.D. Adams, K. Guda, M. Cohen, A.E. Sloan, and T. LaFramboise Characterizing mutational heterogeneity in a glioblastoma patient with double recurrence PLoS ONE 7 2012 e35262
22. F. Notta, C.G. Mullighan, J.C. Wang, A. Poeppl, S. Doulatov, L.A. Phillips, J. Ma, M.D. Minden, J.R. Downing, and J.E. Dick Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells Nature 469 2011 362 367
23. P.C. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
24. A.P. Patel, I. Tirosh, J.J. Trombetta, A.K. Shalek, S.M. Gillespie, H. Wakimoto, D.P. Cahill, B.V. Nahed, W.T. Curry, and R.L. Martuza Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma Science 344 2014 1396 1401
25. S.G. Piccirillo, B.A. Reynolds, N. Zanetti, G. Lamorte, E. Binda, G. Broggi, H. Brem, A. Olivi, F. Dimeco, and A.L. Vescovi Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells Nature 444 2006 761 765
26. S.G. Piccirillo, R. Combi, L. Cajola, A. Patrizi, S. Redaelli, A. Bentivegna, S. Baronchelli, G. Maira, B. Pollo, and A. Mangiola Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution Oncogene 28 2009 1807 1811
27. S.G. Piccirillo, S. Dietz, B. Madhu, J. Griffiths, S.J. Price, V.P. Collins, and C. Watts Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin Br. J. Cancer 107 2012 462 468
28. N.E. Potter, L. Ermini, E. Papaemmanuil, G. Cazzaniga, G. Vijayaraghavan, I. Titley, A. Ford, P. Campbell, L. Kearney, and M. Greaves Single-cell mutational profiling and clonal phylogeny in cancer Genome Res. 23 2013 2115 2125
29. M. Shackleton, E. Quintana, E.R. Fearon, and S.J. Morrison Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 2009 822 829
30. J.R. Shapiro, W.K. Yung, and W.R. Shapiro Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas Cancer Res. 41 1981 2349 2359
31. S. Shete, F.J. Hosking, L.B. Robertson, S.E. Dobbins, M. Sanson, B. Malmer, M. Simon, Y. Marie, B. Boisselier, and J.Y. Delattre Genome-wide association study identifies five susceptibility loci for glioma Nat. Genet. 41 2009 899 904
32. M. Snuderl, L. Fazlollahi, L.P. Le, M. Nitta, B.H. Zhelyazkova, C.J. Davidson, S. Akhavanfard, D.P. Cahill, K.D. Aldape, and R.A. Betensky Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma Cancer Cell 20 2011 810 817
33. A. Sottoriva, I. Spiteri, S.G. Piccirillo, A. Touloumis, V.P. Collins, J.C. Marioni, C. Curtis, C. Watts, and S. Tavaré Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics Proc. Natl. Acad. Sci. USA 110 2013 4009 4014
34. S.N. Stacey, P. Sulem, A. Jonasdottir, G. Masson, J. Gudmundsson, D.F. Gudbjartsson, O.T. Magnusson, S.A. Gudjonsson, B. Sigurgeirsson, K. Thorisdottir Swedish Low-risk Colorectal Cancer Study Group. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility Nat. Genet. 43 2011 1098 1103
35. W. Stummer, U. Pichlmeier, T. Meinel, O.D. Wiestler, F. Zanella, H.J. Reulen ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial Lancet Oncol. 7 2006 392 401
36. N.J. Szerlip, A. Pedraza, D. Chakravarty, M. Azim, J. McGuire, Y. Fang, T. Ozawa, E.C. Holland, J.T. Huse, and S. Jhanwar Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response Proc. Natl. Acad. Sci. USA 109 2012 3041 3046
37. M. Wrensch, R.B. Jenkins, J.S. Chang, R.F. Yeh, Y. Xiao, P.A. Decker, K.V. Ballman, M. Berger, J.C. Buckner, and S. Chang Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility Nat. Genet. 41 2009 905 908